Breast cancer, Secondary cancers
Results
Phase 3
This study looked at pertuzumab (Perjeta) and trastuzumab (Herceptin) with a taxane chemotherapy drug. It was for people with breast cancer that was .
This study was open to women and men whose breast cancer had spread into surrounding tissue (locally advanced breast cancer). And to those whose cancer had spread to another part of their body (secondary breast cancer).
This study was open for people to join between 2012 and 2014. The team published the results in 2020.
Recruitment start: 31 May 2012
Recruitment end: 19 February 2014
Please note: In order to you will need to discuss it with your doctor, unless otherwise specified.
Dr David Miles
Experimental Cancer Medicine Centre (ECMC)
NIHR Clinical Research Network: Cancer
Roche
Last reviewed: 23 Apr 2023
CRUK internal database number: 9440
About Cancer generously supported by Dangoor Education since 2010. Learn more about Dangoor Education
Search our clinical trials database for all cancer trials and studies recruiting in the UK.
Connect with other people affected by cancer and share your experiences.
Questions about cancer? Call freephone 0808 800 40 40 from 9 to 5 - Monday to Friday. Alternatively, you can email us.
